Digoxin and its related endogenous factors.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Critical reviews in clinical laboratory sciences

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.3109/10408369708998094PMID 9226105
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Endogenous Druglike Substances: Implications and Approaches to Their Study

  2015cited by this paper
• Passage of digoxin into cerebrospinal fluid in man.

  2009cited by this paper
• Effect of quinidine on digoxin bioavailability

  2004cited by this paper
• Digoxin-interactions in man: Spironolactone reduces renal but not biliary digoxin clearance

  2004cited by this paper
• Effect of salbutamol on digoxin pharmacokinetics

  2004cited by this paper
• Nighttime dosing assures postdistribution sampling for therapeutic drug monitoring of digoxin.

  1996cited by this paper
• Meeting Highlights American College of Cardiology 45th Annual Scientific Session, Orlando, Florida, March 24 to 27, 1996

  1996cited by this paper
• How to choose a cardiac surgeon

  1996cited by this paper
• Simultaneous isolation of endogenous digoxin-like immunoreactive factor, ouabain-like factor, and deglycosylated congeners from mammalian tissues.

  1996cited by this paper
• Evidence for presence of a reduced form of digoxin-like immunoreactive factor (dihydro-DLIF) in mammalian tissues.

  1996cited by this paper
• Relationship of Na-K-ATPase inhibitors to blood-pressure regulation in continuous ambulatory peritoneal dialysis and hemodialysis.

  1996cited by this paper
• Inhibition of Na,K-ATPase by oleandrin and oleandrigenin, and their detection by digoxin immunoassays.

  1996cited by this paper
• Digoxinlike toxicity and death from a purported aphrodisiac.

  1996cited by this paper
• Rationale, design, implementation, and baseline characteristics of patients in the DIG trial: a large, simple, long-term trial to evaluate the effect of digitalis on mortality in heart failure.

  1996cited by this paper
• Deglycosylated Products of Endogenous Digoxin-like Immunoreactive Factor in Mammalian Tissue (*)

  1996cited by this paper
• Analytical performance of a monoclonal digoxin assay with increased specificity on the ACS:180.

  1996cited by this paper
• The Na+, K+ pump in skeletal muscle: quantification, regulation and functional significance.

  1996cited by this paper
• Importance of using molar concentrations to express cross-reactivity in immunoassays.

  1995cited by this paper
• Ouabain: a new steroid hormone?

  1995cited by this paper
• Effect of long-term digoxin therapy on autonomic function in patients with chronic heart failure.

  1995cited by this paper
• Effects of increasing maintenance dose of digoxin on left ventricular function and neurohormones in patients with chronic heart failure treated with diuretics and angiotensin-converting enzyme inhibitors.

  1995cited by this paper
• Pharmacokinetic Aspects of Digoxin-Specific Fab Therapy in the Management of Digitalis Toxicity

  1995cited by this paper
• Treatment of Human Serum with Sulfosalicylic Acid Structurally Alters Digoxin and Endogenous Digoxin‐Like Immunoreactive Factor

  1995cited by this paper
• Is it safe to prescribe digoxin after acute myocardial infarction? Update on continued controversy.

  1995cited by this paper
• Digitalis-like factor and digoxin-like immunoreactive factor in diabetic women with preeclampsia, transient hypertension of pregnancy, and normotensive pregnancy.

  1995cited by this paper
• Problems in determining levels of free digoxin in patients treated with digoxin immune fab

  1995cited by this paper
• An immunohistochemical study of the significance of a new 31.5-kD ouabain receptor protein isolated from cat cardiac muscle.

  1995cited by this paper
• Digoxin and mortality in survivors of acute myocardial infarction: Observations in patients at low and intermediate risk

  1995cited by this paper
• Activated charcoal increases digoxin elimination in patients.

  1995cited by this paper
• Evaluation and Comparison of the TDXII, Stratus, and OPUS Digoxin Assays

  1995cited by this paper
• Capillary electrophoretic enzyme immunoassay for digoxin in human serum.

  1995cited by this paper
• Hypertension in children and adolescents.

  1995cited by this paper
• Effect of ingesta and of tablets of different strengths on the systemic availability of digoxin in normal dogs.

  1995cited by this paper
• Beneficial effect of digoxin-specific Fab antibody fragments in oleander intoxication.

  1995cited by this paper
• The changing syndrome of heart failure: an annotated review as we approach the 21st century

  1994cited by this paper
• Acute digoxin overdose in a newborn with renal failure: use of digoxin immune Fab and peritoneal dialysis.

  1994cited by this paper
• Digoxinlike immunoreactive substance in critically ill patients.

  1994cited by this paper
• Electrochemical enzyme immunoassay using sequential saturation technique in a 20-μl capillary: digoxin as a model analyte

  1994cited by this paper
• The influence of tocolytic therapy on serum digoxin-like immunoreactive substance concentration.

  1994cited by this paper
• Endogenous digoxin‐like factor in acute myocardial infarction

  1994cited by this paper
• Digoxin-like inhibitors of active sodium transport and blood pressure: the current status.

  1994cited by this paper
• Regulation of Na,K-ATPase by Endogenous Ouabain-like Materials

  1994cited by this paper
• Digoxinlike Immunoreactive Substance in Critically III Patients

  1994cited by this paper
• Digoxin Measurements following Plasma Ultrafiltration in Two Patients with Digoxin Toxicity Treated with Specific Fab Fragments

  1994cited by this paper
• Endogenous digoxin-like substance in liver failure.

  1994cited by this paper
• Understanding the sodium pump and its relevance to disease.

  1994cited by this paper
• Digoxin immunoassay with cross-reactivity of digoxin metabolites proportional to their biological activity.

  1994cited by this paper
• Influence of digoxin‐like immunoreactive factor on late complications in patients with diabetes mellitus

  1994cited by this paper
• Interaction of hypothalamic Na,K-ATPase inhibitor with isolated human peripheral blood mononuclear cells

  1994cited by this paper
• Cloning and characterization of the entire cDNA encoded by ATP1AL1 — a member of the human Na,K/H,K‐ATPase gene family

  1994cited by this paper
• Ouabain is secreted by bovine adrenocortical cells.

  1994cited by this paper
• Comparative hemodynamic effects of intravenous digoxin and enoximone in severe chronic heart failure.

  1994cited by this paper
• Digoxin Disposition in Elderly Humans with Hypochlorhydria

  1994cited by this paper
• Physicochemical characterization of a ouabain isomer isolated from bovine hypothalamus.

  1993cited by this paper
• Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study.

  1993cited by this paper
• Hypothalamic Na+,K(+)-ATPase inhibitor constricts pulmonary arteries of spontaneously hypertensive rats.

  1993cited by this paper
• Intracellular Na+ activity of "diseased" human atrial muscles and its modifications by dihydro-ouabain.

  1993cited by this paper
• Does any correlation exist between a high plasma digoxin concentration and an electrocardiogram in younger and older patients.

  1993cited by this paper
• [Observations on serum digoxin-like immunoreactive substances in patients with cor-pulmonale].

  1993cited by this paper
• Digoxin therapeutic drug monitoring practices. A College of American Pathologists Q-Probes study of 666 institutions and 18,679 toxic levels.

  1993cited by this paper
• The chronic effects of long-term digoxin administration on Na+/K(+)-ATPase activity in rat tissues.

  1993cited by this paper
• RELEASE OF A SUBSTANCE FROM THE HUMAN PLACENTA HAVING DIGOXIN‐LIKE IMMUNOREACTIVITY

  1993cited by this paper
• Digoxin—Doubts to dampen enthusiasm

  1993cited by this paper
• Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED Investigative Group.

  1993cited by this paper
• Endogenous digoxin‐immunoreactive substance in normal and preeclamptic pregnancies

  1993cited by this paper
• Mechanisms of sodium and chloride transport across isolated sheep reticulum.

  1993cited by this paper
• Digoxin activates sarcoplasmic reticulum Ca2+‐release channels: a possible role in cardiac inotropy

  1993cited by this paper
• Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors.

  1993cited by this paper
• Treatment of foxglove extract poisoning with digoxin-specific Fab fragments.

  1993cited by this paper
• The current role of digoxin in the treatment of heart failure.

  1993cited by this paper
• Differential regulation of sodium pump isoforms in heart.

  1992cited by this paper
• A rapid assay for the measurement of Na+,K(+)-ATPase inhibitors.

  1992cited by this paper
• Digoxin-Like Immunoreactive Substance in Urine of Patients with Mucocutaneous Lymph Node Syndrome (MCLS)

  1992cited by this paper
• Development of a radioreceptor assay to measure glucocorticoids.

  1992cited by this paper
• Frequency Domain Measures of Heart Period Variability and Mortality After Myocardial Infarction

  1992cited by this paper
• Inhibition by basic drugs of digoxin secretion into human bile

  1992cited by this paper
• The Contribution of Steroids to Digoxin-Like Immunoreactivity in Cord Blood

  1992cited by this paper
• The Na,K-pump.

  1992cited by this paper
• Intestinal absorption of drugs: digitalis binding and transport by brush-border membrane vesicles from human duodenum.

  1991cited by this paper
• Digoxin-specific Fab fragments in the treatment of oleander toxicity in a canine model.

  1991cited by this paper
• Isolation of digoxin-like immunoreactive factors from mammalian adrenal cortex.

  1991cited by this paper
• Digoxin-induced vasoconstriction of normal and atherosclerotic epicardial coronary arteries.

  1991cited by this paper
• Metabolism of digoxin, digoxigenin digitoxosides and digoxigenin in human hepatocytes and liver microsomes

  1991cited by this paper
• Overview: subunit diversity in the Na,K-ATPase.

  1991cited by this paper
• Molecular genetics of Na,K-ATPase.

  1990cited by this paper
• Treatment of 150 cases of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments. Final report of a multicenter study.

  1990cited by this paper
• A ligand-receptor binding assay of urinary and circulating endogenous digitalis-like factors

  1990cited by this paper
• Digoxin‐Like Immunoreactivity in Chinese Medicine

  1990cited by this paper
• Dichlorobenzoquinone chloroimine colorimetry of uric acid in urine.

  1990cited by this paper
• Treatment of 150 cases of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments

  1990cited by this paper
• Effects of digoxin immune Fab (ovine) on digoxin immunoassays.

  1989cited by this paper
• Detection of poisoning by plant-origin cardiac glycoside with the Abbott TDx analyzer.

  1989cited by this paper
• A physician's office-based digoxin assay (Seralyzer) evaluated for interference by endogenous digoxin-like immunoreactive factors.

  1989cited by this paper
• Improved liquid chromatographic/immunoassay of digoxin in serum.

  1988cited by this paper
• Secretion of atrial natriuretic peptide and digoxin-like immunoreactive substance during pregnancy.

  1988cited by this paper
• Criteria for identifying endogenous compounds as digoxin-like immunoreactive factors in humans.

  1988cited by this paper
• False-positive serum digoxin concentrations determined by three digoxin assays in patients with liver disease.

  1988cited by this paper
• Endogenous cardiac glycoside-like substances in newborns, adults, pregnant women and patients with hypertension or renal insufficiency.

  1988cited by this paper
• Endogenous digoxin-like immunoreactivity in blood is increased during prolonged strenuous exercise.

  1988cited by this paper
• Oleander poisoning: treatment with digoxin-specific Fab antibody fragments.

  1988cited by this paper

• The cardiac glycoside ZINC253504760 induces parthanatos-type cell death and G2/M arrest via downregulation of MEK1/2 phosphorylation in leukemia cells

  2023cites this paper
• Significant Improvement in Digoxin Immunoassays Over Four Decades: Newer Assays are Less Affected by Interferences

  2023cites this paper
• Evaluating the confounding effects of medical therapies on potassium intake assessment in patients with heart failure.

  2020cites this paper
• An up-to-date review of digoxin toxicity and its management

  2019cites this paper
• Issues of interferences in therapeutic drug monitoring

  2019cites this paper
• Immunoassays and Issues With Interference in Therapeutic Drug Monitoring

  2016cites this paper
• Digoxin use may increase the relative risk of acute pancreatitis.

  2015cites this paper
• Bipolar (Manic Depressive) Disorders

  2015cites this paper
• Advances in understanding the role of cardiac glycosides in control of sodium transport in renal tubules.

  2014cites this paper
• Novel role of ouabain as a cystogenic factor in autosomal dominant polycystic kidney disease.

  2013cites this paper
• Challenges in Therapeutic Drug Monitoring of Digoxin and Other Anti-Arrhythmic Drugs

  2012cites this paper
• Impact of Interferences Including Metabolite Crossreactivity on Therapeutic Drug Monitoring Results

  2012cites this paper
• Challenges in Therapeutic Drug Monitoring of Digoxin Using Immunoassays

  2012cites this paper
• Does liquid chromatography-tandem mass spectrometry have a role in therapeutic drug monitoring of digoxin?

  2010cites this paper
• Occurrence of progesterone and related animal steroids in two higher plants.

  2010cites this paper
• Measuring the Unbound Concentration Fails to Resolve Analytic Interferences in Digoxin Immunoassays

  2008cites this paper
• Autonomic nervous system mediates the cardiovascular effects of Rhodiola sacra radix in rats.

  2008cites this paper
• Effect of Spironolactone, Potassium Canrenoate and Their Common Metabolite Canrenone on Serum Digoxin Measurement by Digoxin III, a New Digoxin Immunoassay

  2008cites this paper
• Proteomic and microarray identification of novel cardiac specific indicators of oxidative injury and mechanism of action

  2007cites this paper
• Usefulness of monitoring free (unbound) concentrations of therapeutic drugs in patient management.

  2007cites this paper
• Novel and potential future biomarkers for assessment of the severity and prognosis of chronic heart failure

  2006cites this paper
• Selective inhibition of brain Na,K-ATPase by drugs.

  2006cites this paper
• Novel and potential future biomarkers for assessment of the severity and prognosis of chronic heart failure : a clinical review.

  2006cites this paper
• Suspected DLIS Interference in the Dimension DGNA Digoxin Assay Method and the Clinical Application of the Revised Digoxin Target Range

  2006cites this paper
• Low-dose ouabain protects against excitotoxic apoptosis and up-regulates nuclear Bcl-2 in vivo.

  2006cites this paper
• Multiple Drug Resistant 1 Gene C 3435 T Polymorphism and its Relation to Digoxin Blood Level in Cardiac Patients

  2006cites this paper
• Changing characteristics of the TDx digoxin II assay in detecting bufadienolides in a traditional Chinese medicine: for better or worse?

  2005cites this paper
• New Enzyme-Linked Immunosorbent Digoxin Assay on the ADVIA® IMS™ 800i System Is Virtually Free from Interference of Endogenous Digoxin-like Immunoreactive Factors

  2005cites this paper
• Clinical modifiers for heart failure following myocardial infarction

  2005cites this paper
• Pharmacogenomics of Antihypertensive Treatment a Clinical Pharmacological Studies of Digoxin Treatment

  2005cites this paper
• Interference of Endogenous Digoxin-Like Immunoreactive Factors in Serum Digoxin Measurement is Minimized in a New Turbidimetric Digoxin Immunoassay on ADVIA 1650 Analyzer

  2004cites this paper
• Cystatin C vs creatinine as markers of renal function in patients on digoxin treatment

  2004cites this paper
• Expression, regulation and function of Na,K-ATPase in the lens.

  2004cites this paper
• "Smart" mobile affinity matrix for microfluidic immunoassays.

  2004cites this paper
• Strategies for developing biomarkers of heart failure.

  2004cites this paper
• Digoxin-Like Immunoreactive Substance in Nonoliguric Hyperkalemia of the Premature Infant

  2003cites this paper
• Development of an In Vitro Test Battery for the Estimation of Acute Human Systemic Toxicity: An Outline of the EDIT Project

  2002cites this paper
• Isoform-specific Stimulation of Cardiac Na/K Pumps by Nanomolar Concentrations of Glycosides

  2002cites this paper
• Comparable effects of DIGIBIND and DigiFab in thirteen digoxin immunoassays.

  2002cites this paper
• Digoxin assays: frequent, substantial, and potentially dangerous interference by spironolactone, canrenone, and other steroids.

  2002cites this paper
• CHAPTER 21 – Cardiac Na+/K+ Pump

  2001cites this paper
• Association of ocular pressure and optic disc cup volume with red blood cell sodium-potassium ATPase inhibition

  2000cites this paper
• Lack of Pharmacokinetic Interaction between Gemifloxacin and Digoxin in Healthy Elderly Volunteers

  1999cites this paper
• Plasma and Cerebrospinal Fluid Endogenous Digoxin-Like Immunoreactivity in Patients with Aneurysmal Subarachnoid Haemorrhage

  1999cites this paper
• Validity of unbound digoxin measurements by immunoassays in presence of antidote (Digibind).

  1999cites this paper
• Stimulation of specific binding of [3H]-progesterone to bovine luteal cell-surface membranes: specificity of digitonin.

  1999cites this paper
• Intoxication due to negative canrenone interference in digoxin drug monitoring.

  1999cites this paper
• The role of nitric oxide in digoxin-induced arrhythmias in guinea-pigs.

  1999cites this paper
• Analytical performance of a monoclonal digoxin assay by dry chemistry on the Vitros 950.

  1999cites this paper
• Transient kinetics and thermodynamics of anthroylouabain binding to Na/K-ATPase.

  1998cites this paper
• Standards of laboratory practice: cardiac drug monitoring

  1998cites this paper
• Standards of laboratory practice: cardiac drug monitoring. National Academy of Clinical Biochemistry.

  1998cites this paper
• Vitros digoxin immunoassay evaluated for interference by digoxin-like immunoreactive factors.

  1998influential citation
• Quantitative Determination of Short-chain Organic Ac- Ids in Urine by Capillary Electrophoresis, Coral Barbas,*

  year unknowncites this paper